Riskpilot← Back to searchSign inGet full accessDocTre Oy
OYActiveY-tunnus 2375115-7Oikotie 3Medical specialists activities · NACE 8622Est. 20101 employees
Revenue 2024
EUR 433K
-3% vs 2023
EBITDA margin
4.7%
+207% vs 2023
Equity ratio
84.3%
Financial strength
Net profit 2024
EUR 3K
+120% vs 2023
| Revenue | EUR 433K | -3% |
| EBITDA | EUR 21K | +207% |
| Net profit | EUR 3K | +120% |
| Total assets | EUR 283K | -5% |
| Equity | EUR 238K | -2% |
| Employees | 1 | — |
Legal name
DocTre Oy
Y-tunnus number
2375115-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
2. joulukuuta 2010
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on työterveys- ja yleislääkärin vastaanottotoiminta, lääketieteellinen koulutus ja konsultointi sekä muut alaan liittyvät terveydenhoidolliset palvelut. Lisäksi yhtiö voi ostaa, omistaa ja myydä osakkeita ja osuuksia sekä harjoittaa sijoitustoimintaa. Yritys voi toimintaansa varten omistaa osakkeita, osuuksia sekä kiinteistöjä. Lisäksi yhtiö voi ostaa, vuokrata ja myydä toimialoihinsa liittyviä koneita, laitteita ja ohjelmistoja.
Address
Oikotie 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 353 | 421 | 435 | 448 | 433 |
| Staff expenses | −129 | −184 | −256 | −254 | −251 |
| EBITDA | 121 | 99 | 10 | 7 | 21 |
| Depreciation & amort. | −16 | −13 | −12 | −19 | −16 |
| EBIT | 105 | 87 | −2 | −13 | 5 |
| Net financials | −1 | −1 | −0 | −1 | −2 |
| Profit before tax | 104 | 86 | −2 | −14 | 3 |
| Tax | 21 | 18 | 0 | 1 | −0 |
| Net profit | 83 | 68 | −2 | −15 | 3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 285 | 327 | 290 | 298 | 283 |
| Equity | 246 | 294 | 272 | 244 | 238 |
| Long-term debt | 27 | 16 | 6 | 0 | 0 |
| Short-term debt | 13 | 16 | 11 | 0 | 0 |
| Total debt | 39 | 32 | 18 | 54 | 44 |
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
20202024
Equity ratio
84.3%
This company
38.2%
Market median
+121% vs market
20202024
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
1.53×
This company
1.12×
Market median
+37% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SH Chief Executive Officer | Chief Executive Officer | 2010 |
JP Deputy Member | Deputy Member | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DocTre Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sari Helena Laitinen | Chief Executive Officer | 0 companies |
| Jani Petteri Laitinen | Deputy Member | 0 companies |
| Kia Karoliina Laitinen | Board of Directors | 0 companies |